Lexeo Therapeutics Inc (LXEO)

Investing Cash Flow

$14.26M

Quarterly · Period ending: · USD

LXEO logo

LXEO Investing Cash Flow

Latest reported$14.26M
LXEO Quarterly Cash from Investing (-$173.63K → $14.26M)
High-resolution chart · PNG

LXEO investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
14,264,000
27,460,000
-101,689,000
35,011,000
-39,174,000
15,600,000
-93,583,000
-83,000
-218,000
-193,000
-73,000
-53,000
-39,000
0
-107,000
-400,000
-220,375
-173,625
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.